Grant Kardachi Re-elected as PSA National President
Pharmaceutical Society of Australia National President Grant Kardachi has been re-elected for a fourth term.
The PSA National Board met in Canberra today and also re-elected Joe Demarte as Vice President and elected Michelle Lynch as the other Vice President.
Mr Kardachi said he was honoured to be have been chosen once again by the Board to lead the 18,000-strong PSA over the coming year.
“Over the past few years PSA has gained greater respect, recognition and acceptance as being the major representative voice of the whole of the pharmacy profession in this country,” Mr Kardachi said.
“PSA has members from all sectors of the pharmacy profession from all areas of Australia and this gives the Society strength as well as great responsibility.
“We are also entering an important period for the profession with negotiations for the next Community Pharmacy Agreement set to begin soon and new business models for the way we practise becoming increasingly important to our sustainability.”
Mr Kardachi said PSA had developed close working relationships with a wide range of stakeholders with a view to seeking opportunities for pharmacists while also improving the health outcomes of the communities that pharmacists serve.
“The next year will no doubt again be one that challenges us as a profession but it is how we rise to those challenges that defines us one of the most respected of all professions in this country,” he said.
Mr Kardachi said he was delighted to have two Vice Presidents of the calibre of Ms Lynch and Mr Demarte to work with.
“These two Vice Presidents bring great skills and expertise to the Board at a critical time for pharmacists,” Mr Kardachi said.
“The depth of the new PSA Board Executive will give us added strength in our advocacy for our members and will ensure that PSA continues to be the voice of pharmacy.
“I would also like to thank the outgoing Vice President, Dr Claire O’Reilly, for her commitment and dedication to PSA and all its members during her terms in office.”
Australia has ranked #40 in an index of 50 countries in a global study comparing the cost of some...
The release of new European guidelines on dyslipidaemias has called Australia’s LDL-C...
Professor Brendan Crabb received the 2019 GSK Award for Research Excellence for his research on...